FluiDx-AD
Developing a test trio for enhanced diagnosis & management of Alzheimer's.
X
X
Visit our website
Visit our website
FluiDx-AD is a collaborative Horizon Europe-funded project aimed at improving Alzheimer’s disease diagnosis and management.
FluiDx-AD introduction
Vimeo
FluiDx-AD introduction
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither…
Newsletter sign-up
Newsletter sign-up
FluiDx-AD Email Forms
LinkedIn
LinkedIn
FluiDx-AD | 91 followers on LinkedIn. Our mission is to develop a novel test trio for enhanced diagnosis and management of Alzheimer's disease. | FluiDx-AD seeks to develop a trio of complementary tests: SalivaDx-AD: An easy-to-use, at-home saliva test for population-wide detection of individuals at risk of developing AD in its prodromal stages. PlasmaDx-AD: A minimally invasive and cost-effective blood test for high-precision confirmatory diagnosis for individuals with suspected AD. BloodCellDx-AD: A minimally invasive, whole blood ex vivo test system to evaluate the risk of amyloid-related imaging abnormalities (ARIA), to support patient eligibility assessments and ARIA monitoring for anti-amyloid therapies
Bluesky
Bluesky
Publications repository
Publications repository
View on mobile